These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21778901)

  • 41. Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
    Hsu SC; Lee YY; Wang MC; Liu HL; Cheng MF; Huang JJ
    Blood Purif; 2004; 22(2):224-8. PubMed ID: 15044822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
    Qunibi W; Moustafa M; Muenz LR; He DY; Kessler PD; Diaz-Buxo JA; Budoff M;
    Am J Kidney Dis; 2008 Jun; 51(6):952-65. PubMed ID: 18423809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
    Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
    Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
    Raggi P; Bommer J; Chertow GM
    J Heart Valve Dis; 2004 Jan; 13(1):134-41. PubMed ID: 14765851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of sevelamer on mineral and lipid abnormalities in hemodialysis patients.
    Hamida FB; Fatma LB; Barbouch S; Kaaroud H; Helal I; Hedri H; Abdallah TB; Maiz HB; Kheder A
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):183-8. PubMed ID: 18310864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis.
    Huybrechts KF; Caro JJ; Wilson DA; O'Brien JA
    Value Health; 2005; 8(5):549-61. PubMed ID: 16176493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tumoral calcinoses in a chronic hemodialysis patient: The role of SPECT/CT hybrid imaging].
    Matrane A; Hiroual S; Bsiss MA; Doubli SB
    Nephrol Ther; 2018 May; 14(3):162-166. PubMed ID: 29287893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical effects of the new phosphorus binder, bixalomer in hemodialysis patients switched from sevelamer hydrochloride.
    Gen S; Sasaki T; Saito K; Nobe K; Nodaira Y; Ikeda N
    Ther Apher Dial; 2014 Jun; 18 Suppl 2():8-12. PubMed ID: 24975889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of sevelamer in chronic kidney disease: beyond phosphorus control.
    Rodríguez-Osorio L; Zambrano DP; Gracia-Iguacel C; Rojas-Rivera J; Ortiz A; Egido J; González Parra E
    Nefrologia; 2015; 35(2):207-17. PubMed ID: 26300515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid, progressive tumoral calcinosis mimicking treatment-resistant rheumatoid arthritis.
    Vordenbäumen S; Sewerin P; Al-Neyadi T; Sellin L; Sander O; Laubenthal L; Specker C; Scherer A; Schneider M
    J Clin Rheumatol; 2012 Apr; 18(3):164-5. PubMed ID: 22456524
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
    Inoue T; Nagatoya K; Kagitani M; Shibahara N; Ueda H; Katsuoka Y; Ohashi S; Kitagawa Y; Nishimoto K; Yasuda H;
    Ther Apher Dial; 2007 Jun; 11(3):210-4. PubMed ID: 17498003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
    Ogata H; Koiwa F; Shishido K; Kinugasa E
    Ther Apher Dial; 2005 Feb; 9(1):11-5. PubMed ID: 15828900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sevelamer.
    Wrong O; Harland C
    Nephrol Dial Transplant; 2008 Jun; 23(6):2108; author reply 2101-2. PubMed ID: 18400812
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of switching from sevelamer hydrochloride to bixalomer on laboratory parameters in hemodialysis patients.
    Furukawa K; Ikawa T; Yokoi S; Yokouchi S; Kato K; Ueno M; Takahashi J
    Ther Apher Dial; 2014 Jun; 18 Suppl 2():2-7. PubMed ID: 24975888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uremic tumoral calcinosis of the foot mimicking infection.
    García S; Cofán F; Fernández de RP; Sala P; Oppenheimer F
    Foot Ankle Int; 2002 Mar; 23(3):260-3. PubMed ID: 11934071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resolution of tumoral calcinosis in a hemodialysis patient using low calcium dialysate.
    Franco M; Albano L; Gaid H; Gigante M; Barrillon D; Jaeger P
    Joint Bone Spine; 2005 Jan; 72(1):95-7. PubMed ID: 15681261
    [No Abstract]   [Full Text] [Related]  

  • 58. Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.
    Zhang Q; Li M; Lu Y; Li H; Gu Y; Hao C; Chen J
    Nephron Clin Pract; 2010; 115(4):c259-67. PubMed ID: 20424476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
    Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
    Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.